Deepak Choudhury

Dr. Deepak Choudhury

Biomanufacturing Technology Group, Bioprocessing Technology Institute, Singapore 138668, Singapore
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
SSSatnam Singh
Satnam Singh
Deepak ChoudhuryDeepak Choudhury
Deepak Choudhury
FYFang Yu
Fang Yu
VMVladimir Mironov
Vladimir Mironov
MNMay Win Naing
May Win Naing

1 August 2018 in Trends in Biotechnology
Verified
Journal Article
Closed access
Deepak ChoudhuryDeepak Choudhury
Deepak Choudhury
HTHan Win Tun
Han Win Tun
TWTianyi Wang
Tianyi Wang
MNMay Win Naing
May Win Naing

20 June 2021 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
JSJasmine Si Han Seah
Jasmine Si Han Seah
SSSatnam Singh
Satnam Singh
Lay TanLay Tan
Lay Tan
Deepak ChoudhuryDeepak Choudhury
Deepak Choudhury
The cultured meat market has been growing at an accelerated space since the first creation of cultured meat burger back in 2013. Substantial efforts have been made to reduce costs by eliminating serum in growth media and improving process efficiency by employing bioreactors. In parallel, efforts are also being made on scaffolding innovations to offer better cells proliferation, differentiation and tissue development. So far, scaffolds used in cultured meat research are predominantly collagen and gelatin, which are animal-derived. To align with cell-based meat vision i.e. environment conservation and animal welfare, plant-derived biomaterials for scaffolding are being intensively explored. This paper reviews and discusses the advantages and disadvantages of scaffold materials and potential scaffolding related to scale-up solution for the production of cultured meat. Graphical Abstract

27 February 2019 in Micromachines
Verified
Journal Article
Open access
PDF file
FYFang Yu
Fang Yu
WHWalter Hunziker
Walter Hunziker
Deepak ChoudhuryDeepak Choudhury
Deepak Choudhury
In vitro cell culture models are emerging as promising tools to understand human development, disease progression, and provide reliable, rapid and cost-effective results for drug discovery and screening. In recent years, an increasing number of in vitro models with complex organization and controlled microenvironment have been developed to mimic the in vivo organ structure and function. The invention of organoids, self-organized organ-like cell aggregates that originate from multipotent stem cells, has allowed a whole new level of biomimicry to be achieved. Microfluidic organoid-on-a-chip platforms can facilitate better nutrient and gas exchange and recapitulate 3D tissue architecture and physiology. They have the potential to transform the landscape of drug development and testing. In this review, we discuss the challenges in the current organoid models and describe the recent progress in the field of organoid-on-a-chip.

21 September 2020 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
Harish HandralHarish Handral
Harish Handral
STShi Hua Tay
Shi Hua Tay
WCWeng Wan Chan
Weng Wan Chan
Deepak ChoudhuryDeepak Choudhury
Deepak Choudhury
Three-dimensional (3D) printing is a fast-developing digital technology with colossal market scope in food and nutrition technology, providing a platform for establishing unique food products with enhanced sensory and nutritional value for a particular end-user. Cultured meat is the concept of producing meat sustainably in laboratory conditions without the sacrifice of animal life and the excessive use of antibiotics. 3D printing could offer unique solutions for the vital issues of cultured meat production; particularly on regulating the protein, fat, and other nutritional content, along with providing realistic texture. This review highlights the immense benefits of 3D printing technology for the scalable and reproducible production of cultured meat products.

31 July 2018 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
Deepak ChoudhuryDeepak Choudhury
Deepak Choudhury
SAShivesh Anand
Shivesh Anand
MNMay Win Naing
May Win Naing
The dawn of commercial bioprinting is rapidly advancing the tissue engineering field. In the past few years, new bioprinting approaches as well as novel bioinks formulations have emerged, enabling biological research groups to demonstrate the use of such technology to fabricate functional and relevant tissue models. In recent years, several companies have launched bioprinters pushing for early adoption and democratisation of bioprinting. This article reviews the progress in commercial bioprinting since the inception, with a particular focus on the comparison of different available printing technologies and important features of the individual technologies as well as various existing applications. Various challenges and potential design considerations for next generations of bioprinters are also discussed.